GWANC
Guardian Wealth Advisors (North Carolina) Portfolio holdings
AUM
$1.42B
1-Year Return
12.48%
This Quarter Return
+9.35%
1 Year Return
+12.48%
3 Year Return
+47.43%
5 Year Return
–
10 Year Return
–
AUM
$658M
AUM Growth
+$69.9M
(+12%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
2.4%
Top 10 Holdings %
Top 10 Hldgs %
51.93%
Holding
466
New
44
Increased
119
Reduced
153
Closed
26
Top Buys
Top Sells
| 1 |
Aptus Defined Risk ETF
DRSK
|
$10.2M |
| 2 |
Aptus Large Cap Enhanced Yield ETF
DUBS
|
$4.73M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
$2.73M |
| 4 |
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
|
$1.8M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.47M |
Sector Composition
| 1 | Technology | 8.89% |
| 2 | Financials | 3.58% |
| 3 | Healthcare | 3.02% |
| 4 | Consumer Discretionary | 2.32% |
| 5 | Consumer Staples | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
MetLife
MET
$52.1B
| $427K | 0.06% |
6,460
-180
| -3% | -$11.9K |
|
152
Schwab U.S Small- Cap ETF
SCHA
$18.7B
| $427K | 0.06% |
18,058
-162
| -0.9% | -$3.83K |
|
153
iShares Core MSCI EAFE ETF
IEFA
$150B
| $424K | 0.06% |
6,024
-95
| -2% | -$6.68K |
|
154
Travelers Companies
TRV
$61.8B
| $419K | 0.06% |
2,197
+167
| +8% | +$31.8K |
|
155
Vertex Pharmaceuticals
VRTX
$101B
| $418K | 0.06% |
1,029
-31
| -3% | -$12.6K |
|
156
Labcorp
LH
$23.1B
| $413K | 0.06% |
1,818
-6
| -0.3% | -$1.36K |
|
157
Vanguard Information Technology ETF
VGT
$99.7B
| $411K | 0.06% |
850
-24
| -3% | -$11.6K |
|
158
Texas Instruments
TXN
$170B
| $410K | 0.06% |
2,406
-65
| -3% | -$11.1K |
|
159
RTX Corp
RTX
$210B
| $407K | 0.06% |
4,836
+572
| +13% | +$48.1K |
|
160
Nike
NKE
$109B
| $404K | 0.06% |
3,723
-3
| -0.1% | -$326 |
|
161
Synopsys
SNPS
$111B
| $402K | 0.06% |
781
-9
| -1% | -$4.63K |
|
162
iShares Core MSCI Total International Stock ETF
IXUS
$48.1B
| $399K | 0.06% |
6,152
+806
| +15% | +$52.3K |
|
163
Linde
LIN
$219B
| $396K | 0.06% |
964
+306
| +47% | +$126K |
|
164
Emerson Electric
EMR
$74.4B
| $395K | 0.06% |
4,056
-97
| -2% | -$9.44K |
|
165
CVS Health
CVS
$93.4B
| $391K | 0.06% |
4,947
-451
| -8% | -$35.6K |
|
166
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $389K | 0.06% |
2,163
+21
| +1% | +$3.78K |
|
167
ARK Innovation ETF
ARKK
$7.48B
| $384K | 0.06% |
7,335
+1,472
| +25% | +$77.1K |
|
168
SPDR Gold Trust
GLD
$112B
| $381K | 0.06% |
1,991
-62
| -3% | -$11.9K |
|
169
Vanguard Growth ETF
VUG
$186B
| $374K | 0.06% |
1,283
+3
| +0.2% | +$874 |
|
170
Netflix
NFLX
$529B
| $373K | 0.06% |
766
-112
| -13% | -$54.5K |
|
171
Boeing
BA
$172B
| $371K | 0.06% |
1,423
-113
| -7% | -$29.5K |
|
172
Dimensional US Core Equity 2 ETF
DFAC
$37.2B
| $365K | 0.06% |
12,488
+43
| +0.3% | +$1.26K |
|
173
Philip Morris
PM
$251B
| $357K | 0.05% |
3,798
-1,485
| -28% | -$140K |
|
174
Regeneron Pharmaceuticals
REGN
$60.4B
| $356K | 0.05% |
405
-14
| -3% | -$12.3K |
|
175
iShares Morningstar Mid-Cap Value ETF
IMCV
$824M
| $355K | 0.05% |
5,245
-138
| -3% | -$9.35K |
|